Search research articles
Contact Us
Filters
Showing results (51-60 of 173) with videos related to
Page
of 18
Sort By:
American Journal of Physiology. Endocrinology and Metabolism
|
May 12, 2005
Oleylethanolamide impairs glucose tolerance and inhibits insulin-stimulated glucose uptake in rat adipocytes through p38 and JNK MAPK pathways
Carmen González-Yanes, Antonia Serrano, Francisco Javier Bermúdez-Silva, et al.
Addiction Biology
|
November 14, 2018
Cannabinoid dependence induces sustained changes in GABA release in the globus pallidus without affecting dopamine release in the dorsal striatum: A dual microdialysis probe study
Margarita Moreno, Juan Decara, Francisco Javier Pavon, et al.
European Journal of Pharmacology
|
January 21, 2006
Activation of cannabinoid CB1 receptors induces glucose intolerance in rats
Francisco Javier Bermúdez-Siva, Antonia Serrano, Francisco Javier Diaz-Molina, et al.
Nanomedicine (London, England)
|
March 29, 2014
Preparation, characterization and in vivo evaluation of nanoemulsions for the controlled delivery of the antiobesity agent N-oleoylethanolamine
Miguel Wulff-Pérez, Francisco J Pavón, Antonio Martín-Rodríguez, et al.
Addiction Biology
|
June 30, 2017
Fatty acid amide hydrolase (FAAH) inactivation confers enhanced sensitivity to nicotine-induced dopamine release in the mouse nucleus accumbens
Francisco J Pavon, Antonia Serrano, Nimish Sidhpura, et al.
The International Journal of Neuropsychopharmacology
|
October 31, 2013
The systemic administration of oleoylethanolamide exerts neuroprotection of the nigrostriatal system in experimental Parkinsonism
Ramiro Gonzalez-Aparicio, Eduardo Blanco, Antonia Serrano, et al.
Frontiers in Molecular Neuroscience
|
May 10, 2019
Oleoylethanolamide Modulates BDNF-ERK Signaling and Neurogenesis in the Hippocampi of Rats Exposed to Δ<sup>9</sup>-THC and Ethanol Binge Drinking During Adolescence
Daniel Silva-Peña, Patricia Rivera, Francisco Alén, et al.
Addiction Biology
|
February 10, 2016
Oleoylethanolamide prevents neuroimmune HMGB1/TLR4/NF-kB danger signaling in rat frontal cortex and depressive-like behavior induced by ethanol binge administration
María Antón, Francisco Alén, Raquel Gómez de Heras, et al.
Neuroscience and Biobehavioral Reviews
|
November 28, 2018
Neuroplastic and cognitive impairment in substance use disorders: a therapeutic potential of cognitive stimulation
Patricia Sampedro-Piquero, David Ladrón de Guevara-Miranda, Francisco J Pavón, et al.
Addiction Biology
|
November 14, 2018
Ethanol-induced alterations in endocannabinoids and relevant neurotransmitters in the nucleus accumbens of fatty acid amide hydrolase knockout mice
Francisco J Pavón, Antonia Serrano, David G Stouffer, et al.
Page
of 18
Search research articles
Search
Showing results (51-60 of 173) with videos related to
Sort By:
Page
of 18
American Journal of Physiology. Endocrinology and Metabolism
|
May 12, 2005
Oleylethanolamide impairs glucose tolerance and inhibits insulin-stimulated glucose uptake in rat adipocytes through p38 and JNK MAPK pathways
Carmen González-Yanes, Antonia Serrano, Francisco Javier Bermúdez-Silva, et al.
Addiction Biology
|
November 14, 2018
Cannabinoid dependence induces sustained changes in GABA release in the globus pallidus without affecting dopamine release in the dorsal striatum: A dual microdialysis probe study
Margarita Moreno, Juan Decara, Francisco Javier Pavon, et al.
European Journal of Pharmacology
|
January 21, 2006
Activation of cannabinoid CB1 receptors induces glucose intolerance in rats
Francisco Javier Bermúdez-Siva, Antonia Serrano, Francisco Javier Diaz-Molina, et al.
Nanomedicine (London, England)
|
March 29, 2014
Preparation, characterization and in vivo evaluation of nanoemulsions for the controlled delivery of the antiobesity agent N-oleoylethanolamine
Miguel Wulff-Pérez, Francisco J Pavón, Antonio Martín-Rodríguez, et al.
Addiction Biology
|
June 30, 2017
Fatty acid amide hydrolase (FAAH) inactivation confers enhanced sensitivity to nicotine-induced dopamine release in the mouse nucleus accumbens
Francisco J Pavon, Antonia Serrano, Nimish Sidhpura, et al.
The International Journal of Neuropsychopharmacology
|
October 31, 2013
The systemic administration of oleoylethanolamide exerts neuroprotection of the nigrostriatal system in experimental Parkinsonism
Ramiro Gonzalez-Aparicio, Eduardo Blanco, Antonia Serrano, et al.
Frontiers in Molecular Neuroscience
|
May 10, 2019
Oleoylethanolamide Modulates BDNF-ERK Signaling and Neurogenesis in the Hippocampi of Rats Exposed to Δ<sup>9</sup>-THC and Ethanol Binge Drinking During Adolescence
Daniel Silva-Peña, Patricia Rivera, Francisco Alén, et al.
Addiction Biology
|
February 10, 2016
Oleoylethanolamide prevents neuroimmune HMGB1/TLR4/NF-kB danger signaling in rat frontal cortex and depressive-like behavior induced by ethanol binge administration
María Antón, Francisco Alén, Raquel Gómez de Heras, et al.
Neuroscience and Biobehavioral Reviews
|
November 28, 2018
Neuroplastic and cognitive impairment in substance use disorders: a therapeutic potential of cognitive stimulation
Patricia Sampedro-Piquero, David Ladrón de Guevara-Miranda, Francisco J Pavón, et al.
Addiction Biology
|
November 14, 2018
Ethanol-induced alterations in endocannabinoids and relevant neurotransmitters in the nucleus accumbens of fatty acid amide hydrolase knockout mice
Francisco J Pavón, Antonia Serrano, David G Stouffer, et al.
Page
of 18